REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 2 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
Superinvestors holding RGNX, Q2 2026
No superinvestor reported holding RGNX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RGNX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)